Interview: NCCIH Director Josephine Briggs On The Science Supporting More Self-Care
This article was originally published in The Tan Sheet
Executive Summary
In an interview with “The Tan Sheet,” Briggs discusses topics including the lack of data on drug-supplement interactions and NCCIH’s interest in funding research on standards for assessing the clinical importance of those interactions.
You may also be interested in...
NCCAM Director Aim For “Strong Portfolio” Of Studies Despite Funding Limits
National Center for Complementary and Alternative Medicines Director Josephine Briggs started in the post at a time when the center is expected to operate with no increase in federal funding, she says
Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD
A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.
Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations
US FDA oncology officials are concerned that the entities sponsors are consulting in developing and implementing clinical trial diversity plans are not sufficiently diverse themselves and do not represent patients in underserved communities.